, Nov. 21, 2013
/PRNewswire/ -- Philips Respironics, a unit of Royal Philips
(NYSE: PHG, AEX: PHIA) and a pioneer in science-based sleep solutions, brings a new comfort option to its best-selling, most comfortable full face mask that fits most patients. The Amara gel cushion option is part of a groundbreaking series of new masks and services that are setting a new standard for patient care.
To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/64501-philips-respironics-amara-gel-cushion-face-mask-sleep-apnea
The introduction to continuous positive airway pressure (CPAP) therapy and to a full face mask can be challenging for some patients. With its renowned "one-click" design, and new gel cushion option, Amara delivers the performance and ease of use that contribute to help improve patient success.
Both Amara silicone and gel cushions interchangeably snap into one modular frame. With either silicone or gel cushion in place, Amara is smaller and lighter weight than the industry's leading full face mask, and has 60% fewer parts. Patients also can now choose the type of comfort they prefer in their cushion. The new soft gel cushion conforms to the contours of the face, providing exceptional seal and comfort. By providing two cushion options, patients and clinicians have two chances at successful outcomes on one mask system.
"We want to elevate patient and provider satisfaction of our most successful full face mask," said John Frank, senior vice president, general manager, Sleep and Respiratory Care, Philips Home Healthcare Solutions. "The new gel cushion gives patients the ability to customize their experience, while achieving the performance Amara is known for."
For clinicians, Amara offers a comprehensive fitting solution. Four different sizes fits more than 95% of faces. And with Philips Fit for Life solution, every new mask comes complete with resupply service.
"Amara is part of 'The Answer,' our innovative portfolio of masks and services designed to promote healthier patients, healthier businesses, and healthier practices," adds Mr. Frank.
CPAP is a commonly prescribed and proven treatment for sleep apnea, which it is estimated affects 22 million Americans1.
1American Sleep Apnea Association
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
SOURCE Philips Respironics